Filed in archive
Corporate and Industrial News
, Meetings and Other Events
by ruth on February 19, 2006
During the recently concluded 8th Annual BIO CEO & Investor Conference at the Waldorf-Astoria, the Biotechnology

Industry Organization (BIO) announced this year's winners of the James D. Watson Helix Award for Biotechnology Industry Leadership.
Large Capitalization: Genentech Inc., of South San Francisco, Calif.
Emerging Company/Mid-Capitalization: Alnylam Pharmaceuticals Inc., of Cambridge, Mass.
International: Novo Nordisk Inc., of Princeton, N.J.
Read more about the award from BIO. You may want to view webcasts of the companies which participated at the conference here.

Large Capitalization: Genentech Inc., of South San Francisco, Calif.
Emerging Company/Mid-Capitalization: Alnylam Pharmaceuticals Inc., of Cambridge, Mass.
International: Novo Nordisk Inc., of Princeton, N.J.
"These companies have been selected and recognized as industry leaders by being nominated by their peers. Each firm is devoting its resources to developing cutting-edge science that will lead to breakthrough, life saving therapies. I congratulate them for their success and commitment to saving and improving patient lives," said Jim Greenwood, BIO's president and CEO.
Read more about the award from BIO. You may want to view webcasts of the companies which participated at the conference here.
Tags:
biotech
investor
biotechnology
industry
award
biotechnology+industry
james+watson
award+biotechnolog
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/15693
Mr Wong
Vote for James D. Watson Helix Award for Biotechnology Industry Leadership:
|
Rating: 8.00 out of 3 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |







